Your session is about to expire
← Back to Search
Sertraline alone at steady state for Post-Traumatic Stress Disorder
Study Summary
This trial is to see if prazosin or propranolol can lower blood pressure when taken with brexpiprazole/sertraline.
- Post-Traumatic Stress Disorder
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has the combination of Sertraline and brexpiprazole been formally recognized by the FDA?
"The safety of Sertraline and brexpiprazole at a steady state has been judged as having low risk, earning it a score of 1. This is because this is only in the first phase of trials which limits the amount of evidence regarding its efficacy and security."
Are individuals below the age of 50 being considered for participation in this experiment?
"The recruitment criteria for this medical trial necessitates that interested individuals must be over 18 and below 65."
What is the current enrolment capacity for this clinical trial?
"Affirmative, the clinicaltrials.gov website reveals that this trial is open for recruitment with a start date on August 22nd 2022 and an updated version posted on July 28th of the same year. This research requires 24 participants from two distinct sites to complete enrolment."
Is this experiment accepting new participants at the moment?
"Affirmative, the information hosted on clinicaltrials.gov suggests this medical trial is still open to enrolment. The initial post was made on August 22nd 2022 and has since been updated most recently in July 28th 2022. There are 24 prospective patients needed across 2 research facilities."
What has Sertraline + brexpiprazole combination been shown to alleviate?
"Sertraline + brexpiprazole at steady state is typically prescribed to treat angina pectoris, but has also proven useful in combating myocardial infarction, managing post traumatic stress disorder (PTSD), and moderating the effects of adrenergic alpha-antagonists."
Who would be the ideal participants for this medical trial?
"This trial is recruiting 24 adults aged 18 to 65 with moral injury. The applicants must meet the DSM-V criteria for Major Depressive Disorder, PTSD, GAD, Panic Disorders, Social anxiety Disorder or OCD and be able to tolerate a daily dose of 150mg sertraline by their second screening visit (Day -15)."
Share this study with friends
Copy Link
Messenger